¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"band of molecular layer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • radio frequency band
    °íÁÖÆÄ´ë
  • rostral retention band
    ÀÔÂÊÀÜ·ù±Ù¸·
  • molecular
    ºÐÀÚ-
  • molecular air pump
    ºÐÀڽİø±âÆßÇÁ
  • molecular arrangement
    ºÐÀڹ迭
  • molecular attraction
    ºÐÀÚÀηÂ
  • molecular biology
    ºÐÀÚ»ý¹°ÇÐ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°
  • molecular conductivity
    ºÐÀÚÀüµµÀ²
  • molecular disease
    ºÐÀÚº´
  • molecular dispersion
    ºÐÀںлê
  • molecular distillation
    ºÐÀÚÁõ·ù
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö
  • molecular fat
    ºÐÀÚÁö¹æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • radiofrequency band
    °íÁÖÆÄ´ë
  • rostral retention band
    ÀÔÂÊÀÜ·ù±Ù¸·
  • sonolucent band
    ÃÊÀ½ÆÄÅõ°ú¶ì
  • molecular arrangement
    ºÐÀڹ迭
  • molecular attraction
    ºÐÀÚÀηÂ
  • molecular biology
    ºÐÀÚ»ý¹°ÇÐ
  • molecular radiation biology
    ºÐÀÚ¹æ»ç¼±»ý¹°ÇÐ
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°
  • molecular conductivity
    ¸ôÀüµµÀ²
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö
  • molecular disease
    ºÐÀÚº´
  • molecular dispersion
    ºÐÀںлê
  • molecular distillation
    ºÐÀÚÁõ·ù
  • molecular weight determination
    ºÐÀÚ·®ÃøÁ¤
  • molecular fat
    ºÐÀÚÁö¹æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Henle s layer
    Çî·¹Ãþ.
  • Henle s layer
    Çî·¹Ãþ
  • Henles fiber layer
    Çî·¹½Å°æ¼¶À¯Ãþ
  • Huxley s layer
    Çä½½¸®Ãþ.
  • Huxley s layer
    Çä½½¸®Ãþ
  • Huxleys layer
    Çä½½¸®Ãþ
  • Langhans layer
    ¶û±×ÇѽºÃþ.
  • Malpighian layer
    ¸»ÇDZâÃþ
  • Nitabuchs layer
    ´ÏŸºÎÈåÃæ.
  • Sattlers layer
    ÀÚÆ²·¯Ãþ
  • adipose layer
    Áö¹æÃþ(ò·Û¸öµ)
  • adipose layer
    Áö¹æÃþ
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • anterior layer
    ¾ÕÃþ
  • arrangement of germinal layer
    Á¾ÀÚÃþ¹è¿­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • band form =stab cell
    °£»óÈ£Áß±¸
  • band forming pliers
    ´ëȯ¼ºÇü°âÀÚ(¡­à÷û¡ÌÆí­).
  • band keratitis
    ¶ì¸ð¾ç°¢¸·¿°, ´ë»ó°¢¸·¿°
  • band keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ, ´ë»ó°¢¸·º´Áõ(¡­Ü»ñø)
  • band matrix
    ´ë»ó°Ýº®(ÓáßÒ̰Ûú).
  • band neutrophil
    ´ëÈ£Áß±¸(Óáû¿ñéϹ)
  • band noise
    ´ë¿ªÀâÀ½
  • band of Broca
    ºê·ÎÄ«¶ì.
  • band path
    ´ëµµ(ÓáÔ³)
  • band pusher
    ´ëȯÃßÁø±â(Óáü»õÏòäÐï) ¡ì±³Á¤¿ë¡í.
  • band removing pliers
    ´ëȯö°Å°âÀÚ(Óáü»ôÌËÛÌÆí­) ¡ì±³Á¤¿ë¡í.
  • band splint
    ´ëȯ ºÎ¸ñ(Óáü»ÜùÙÊ).
  • band-loop space maintainer
    ¹êµå·ç¿ìÇÁ º¸°ÝÀåÄ¡.
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ, ´ë»ó°¢¸·º´Áõ
  • belly band
    º¹´ë(º¹´ë).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Subendothelial layer
    ³»ÇǹØÃþ
    [¿¾ ¿ë¾î] ³»ÇÇÇÏÃþ
  • Ependymal layer
    ³ú½Ç¸·Ãþ
    [¿¾ ¿ë¾î] »óÀÇÃþ
  • Circular muscle layer
    µ¹¸²±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] À±ÁÖ±ÙÃþ
  • Circular layer
    µ¹¸²Ãþ
    [¿¾ ¿ë¾î] À±ÁÖ±ÙÃþ
  • Circular layer
    µ¹¸²Ãþ
    [¿¾ ¿ë¾î] À±ÁÖÃþ
  • Posterior layer
    µÚÃþ
    [¿¾ ¿ë¾î] ÈÄ¿±
  • Supravascular layer
    ¸Æ°üÀ§Ãþ
    [¿¾ ¿ë¾î] ¸Æ°ü»óÃþ
  • Vascular layer
    ¸Æ°üÃþ
    [¿¾ ¿ë¾î] ¸Æ°üÃþ
  • Choriocapillary layer
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
    [¿¾ ¿ë¾î] ¸Æ¶ô¸ð¼¼Ç÷°üÃþ
  • Choroidal capillary layer
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
    [¿¾ ¿ë¾î] ¸Æ¶ô¸ð¼¼°üÆÇ
  • Suprachoroidal layer
    ¸Æ¶ô¸·À§Ãþ
    [¿¾ ¿ë¾î] ¸Æ¶ô»óÆÇ
  • Nonvascular layer
    ¹«Ç÷°üÃþ
    [¿¾ ¿ë¾î] ¹«Ç÷°üÃþ
  • Multiform layer
    ¹µ¸ð¾çÃþ
    [¿¾ ¿ë¾î] ´ÙÇüÃþ
  • External granular layer
    ¹Ù±ù°ú¸³Ãþ
    [¿¾ ¿ë¾î] ¿Ü°ú¸³Ãþ
  • Henle`s layer
    ¹Ù±ù»óÇÇÃþ
    [¿¾ ¿ë¾î] ¸í»óÇÇÃþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gram-molecular weight
    ±×·¥ ºÐÀÚ·®(ÝÂí­Õá)
  • minimum molecular weight
    ÃÖ¼ÒºÐÀÚ·®(õÌá³ÝÂí­Õá)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • molecular clock
    ºÐÀڽðè(ÝÂí­ãÁͪ)
  • molecular cloning
    ºÐÀÚ(ÝÂí­)Ŭ·Î´×
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»)
  • molecular evolution
    ºÐÀÚÁøÈ­(ÝÂí­òäûù)
  • molecular-exclusion chromatography
    ºÐÀÚ¹èÀç(ÝÂí­ÛÉð¶) Å©·Î¸¶ÅäÅ©·¡ÇÇ
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ(ÝÂí­ë¶îîùÊ)
  • molecular hybrid
    ºÐÀÚ(ÝÂí­) Æ¢±â
  • molecular mass
    ºÐÀÚÁú·®(ÝÂí­òõÕá)
  • molecular mimicry
    ºÐÀÚ ÀÇÅÂ(ÝÂí­ëô÷¾)
  • molecular orbital
    ºÐÀڱ˵µ(ÝÂí­ÏùÔ³)
  • molecular orbital theory
    ºÐÀڱ˵µ¼³(ÝÂí­ÏùÔ³àã)
  • molecular photosensitization
    ºÐÀÚ ±¤°¨ÀÛ(ÝÂí­ÎÃÊõíÂ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MB Bachelor of Medicine [Lat. Medicinae Baccalaureus]; buccal margin; isoenzyme of creatine kinase cont...
OB obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici...
Pm paratid midle [band protein]; promethium
HVL Half-Value Layer
GL gland; glomerular layer; glycolipid; glycosphingolipid; glycyrrhizin; greatest length; gustatory lac...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OCB Oligoclonal band
BW band widths
BBN broad band noise
CDB3 cytoplasmic domain of band 3
MS-DB medial septum-diagonal band
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular weight distribution
    ºÐÀÚ·® ºÐÆ÷
  • adipose layer
    Áö¹æ Ãþ
  • aponeurotic layer
    °Ç¸· Ãþ
  • basal epithelial layer
    ±âÀú »óÇÇ Ãþ
  • basal layer of endometrium
    ÀڱüӸ· ¹Ù´ÚÃþ
  • basal-cell layer
    ±âÀú ¼¼Æ÷Ãþ
  • Beilby layer
    ¹ÙÀϺñ Ãþ
    °íµµ·Î ¿¬¸¶µÈ ±Ý¼ÓÀÇ ¹«±¸Á¶Àû ºÐÀÚÀÇ Ç¥¸é Ãþ. °ÅÄ£ °ÍÀ» °¨¼Ò½Ã۱â À§ÇØ °è¼ÓÇØ¼­ ¿¬¸¶ÇØ ¾ò¾îÁø ºñ±³Àû ±ÜÈûÀÌ ¾ø´Â ¹Ì¼¼ °áÁ¤ Ç¥¸é.
  • buffy layer
    ¿¬Ãþ
  • cellular layer
    ¼¼Æ÷ Ãþ
    ¼¼Æ÷°¡ °ÅÀÇ ÀÏÁ¤ÇÑ µÎ²²ÀÇ, ȬÀ̺Ҹð¾çÀÇ Á¶Á÷ ±¸Á¶¸¦ °¡Áö´Â °Í.
  • cellular proliferative layer
    ¼¼Æ÷¼º Áõ½ÄÃþ
    ¼¼Æ÷ÀÇ µ¿ÀÏÇüÅÂÀÇ Àç»ý»ê ¶Ç´Â Áõ½ÄÃþ.
  • choroid layer
    ¸Æ¶ô¸· Ãþ
    Ç÷°üÀ» °¡Áø ¾È±¸ÀÇ Ãþ.
  • compact layer
    Ä¡¹Ð Ãþ
  • double layer
    ÀÌÁß Ãþ
  • double layer fluorescent antibody technique
    ÀÌÃþ Çü±¤ Ç×ü¹ý
  • floegel's layer
    ÇÃ·Ú°Ö Ãþ
    ±Ù ¼¶À¯ÀÇ Åõ¸í ¿Ü°ü¿¡ ÀÖ´Â °ú¸³ Ãþ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
molecular probes A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in molecular genetics to detect the presence of a complementary sequence by molecular hybridization.
(12 Dec 1998)
molecular probe techniques The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms.
(12 Dec 1998)
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
molecular sieve A gel-like material with pore sizes of such ranges as to exclude molecules above certain sizes; used in fractionating or purifying macromolecules.
(05 Mar 2000)
molecular structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number and location of chemical bonds.
(12 Dec 1998)
molecular weight The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
molecular weight ratio The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
heparin, low-molecular-weight <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Pharmacological action: anticoagulant, fibrinolytic agent.
(12 Dec 1998)
directed molecular evolution Techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter.
(12 Dec 1998)
epidemiology, molecular The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
(12 Dec 1998)
european molecular biology lab gene bank <molecular biology> A large database of DNA sequence data in Heidelberg, Germany, compiled from international sources. It is the European equivalent to the Genbank DNA sequence databank in the United States of America.
WWW: EMbase.
(09 Oct 1997)
evolution, molecular Evolution at the molecular level of DNA sequences and proteins. (rieger et al., glossary of genetics: classical and molecular, 5th ed)
(12 Dec 1998)
kinetic molecular theory <chemistry> This theory assumes that molecules must collide in order to react. The more collisions the more likely it is for a reaction to occur.
However, depending on the conditions, only a small fraction of the collisions are effective in producing a reaction. There are several constraints. In order for a reaction to occur, bonds initially are broken, which requires energy. This energy depends on the type of the reaction and comes from the kinetic energies that the molecules possess before the collision. It is called the activation energy. Increasing the temperature increases the kinetic energies and more collisions will occur. In adition, at a higher temperature a greater number of the reacting molecules might possess an energy equal to or greater than the activation energy. However the molecules must also collide in a specific orientation, called the steric factor in order for a reaction to occur.
A reaction will only be successful, if the collision has enough energy to be either equal to or greater than the activation energy and if the orientation of the collision allows for correct bond formation. These factors are in the Arrhenius equation: k = zp The rate constant k is proportional to the Arrhenius factor A. A is the product of the collision frequency z, and the steric factor p. The fraction of collisions with sufficient energy to produce a reaction are in the term of the equation.
(09 Jan 1998)
kininogen, high-molecular-weight A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with prekallikrein. Hmwk is split by plasma kallikrein to produce bradykinin. The complex is a cofactor in the activation of coagulation factor xii. The product of this reaction, xiia, in turn activates prekallikrein to kallikrein.
(12 Dec 1998)
kininogen, low-molecular-weight A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by kallikrein or other kallikreins, it forms kallidin. Kallidin, in turn, is converted into bradykinin.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • band
    ²ö;¹êµå;¶ì;ÀÏ´ë;¾Ç´ë-´Ü°áÇÏ´Ù(together)
  • band hell
    ¾ß¿ÜÀ½¾Ç´ç
  • band saw
    ¶ìÅé
  • band shell
    À½¾Ç´ç
  • citizens band
    ½Ã¹Î ¹êµå(°³ÀÎ¿ë ¹«¼± Åë½Å¿¡ °³¹æµÇ¾î ÀÖ´Â Á֯ļö´ë)
  • citizens band radio
    ½Ã¹Î¹êµå ¶óµð¿À(ÀÏ¹Ý ½Ã¹Î¿¡°Ô Çã¿ëµÈ Á֯ļö´ë¸¦ ÀÌ¿ëÇÑ ¿öŰÅäŰ µîÀÇ ¶óµð¿À)
  • conduction band
    Àüµµ´ë
  • dande band
    ´í½º ¹êµå
  • driving band
    µ¿·Â Àü´Þ º§Æ®
  • elastic band
    (¿µ)°í¹« ¹êµå
  • frequency band
    Á֯ļö´ë
  • headache band
    (¿©ÀÚÀÇ Àå½Ä¿ë)Çì¾î¹êµå
  • jug band
    (Çϸð´ÏÄ«,³¿ºñÀÇ) À⵿»ç´Ï ¾Ç´ë
  • military band
    ±º¾Ç´ë
  • mourning band
    »óÀå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á